Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enzyme replacement in Pompe disease: an attempt with purified human acid alpha-glucosidase.

× No keyword cloud information.

11 in total

1. Acid maltase deficiency: a case study and review of the pathophysiological changes and proposed therapeutic measures.

Authors: H Isaacs; N Savage; M Badenhorst; T Whistler
Journal: J Neurol Neurosurg Psychiatry Date: 1986-09 Impact factor: 10.154

2. Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease.

Authors: A J McVie-Wylie; K L Lee; H Qiu; X Jin; H Do; R Gotschall; B L Thurberg; C Rogers; N Raben; M O'Callaghan; W Canfield; L Andrews; J M McPherson; R J Mattaliano
Journal: Mol Genet Metab Date: 2008-06-05 Impact factor: 4.797

3. Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.

Authors: T Kikuchi; H W Yang; M Pennybacker; N Ichihara; M Mizutani; J L Van Hove; Y T Chen
Journal: J Clin Invest Date: 1998-02-15 Impact factor: 14.808

4. Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk.

Authors: J M Van den Hout; A J Reuser; J B de Klerk; W F Arts; J A Smeitink; A T Van der Ploeg
Journal: J Inherit Metab Dis Date: 2001-04 Impact factor: 4.982

Review 5. The respiratory neuromuscular system in Pompe disease.

Authors: David D Fuller; Mai K ElMallah; Barbara K Smith; Manuela Corti; Lee Ann Lawson; Darin J Falk; Barry J Byrne
Journal: Respir Physiol Neurobiol Date: 2013-06-21 Impact factor: 1.931

Review 6. Consensus treatment recommendations for late-onset Pompe disease.

Authors: Edward J Cupler; Kenneth I Berger; Robert T Leshner; Gil I Wolfe; Jay J Han; Richard J Barohn; John T Kissel
Journal: Muscle Nerve Date: 2011-12-15 Impact factor: 3.217

7. Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases.

Authors: Ana C Puhl; Sean Ekins
Journal: GEN Biotechnol Date: 2022-04-20

Review 8. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.

Authors: Shannon L Macauley
Journal: Pediatr Endocrinol Rev Date: 2016-06

9. Myopathies due to enzyme deficiencies.

Authors: F Cornelio; S Di Donato
Journal: J Neurol Date: 1985 Impact factor: 4.849

10. Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.

Authors: A T Van der Ploeg; M A Kroos; R Willemsen; N H Brons; A J Reuser
Journal: J Clin Invest Date: 1991-02 Impact factor: 14.808